Latest News and Press Releases
Want to stay updated on the latest news?
-
Washington, D.C., June 21, 2023 (GLOBE NEWSWIRE) -- Organizations representing pharmacists and pharmacies are applauding the Protect Patient Access to Pharmacies Act (S. 2052) introduced today in...
-
Washington, D.C., June 21, 2023 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy (NASP), a nonprofit organization representing all specialty pharmacy industry stakeholders, is...
-
Washington, DC, May 25, 2023 (GLOBE NEWSWIRE) -- This week, the House Energy and Commerce Committee passed legislation that supports patients living with life altering and life-threatening medical...
-
Washington, DC, April 04, 2023 (GLOBE NEWSWIRE) -- Last week the Senate took a number of actions to address anticompetitive PBM practices, including the introduction of the Drug Price Transparency...
-
Washington, DC, March 17, 2023 (GLOBE NEWSWIRE) -- On Friday, United States Representatives Buddy Carter (R-GA), Vicente Gonzalez D-TX), Elise Stefanik (R-NY), Deborah Ross (D-NC), Rick Allen...
-
Washington, DC, March 14, 2023 (GLOBE NEWSWIRE) -- Washington, D.C., Mar 14, 2023 (GLOBE NEWSWIRE) – Today, the National Association of Specialty Pharmacy (NASP), the only non-profit organization in...
-
Washington, DC, Sept. 22, 2022 (GLOBE NEWSWIRE) -- National Association of Specialty Pharmacy (NASP) is pleased to announce the winners of specialty pharmacy's highly anticipated Annual Meeting...
-
Washington, DC, Sept. 01, 2022 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy (NASP) welcomes five new board members as it heads into its 2022 Annual Meeting & Expo and 10th...
-
Washington, DC, July 13, 2022 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy (NASP), a nonprofit organization representing all specialty pharmacy industry stakeholders, is...
-
WASHINGTON, DC, June 07, 2022 (GLOBE NEWSWIRE) -- WASHINGTON, DC – The National Association of Specialty Pharmacy (NASP) applauds the decision by the Federal Trade Commission (FTC) to proceed with...